From the Desk of the CEO

Updates from FDA

APhA Staff

As cold and flu season rolls on, so does a spike in calls to poison control centers due to acetaminophen overuse.

Mickie Cathers

Antiviral medications do not make a difference in mortality or admission to the hospital in patients with nonsevere influenza, according to a systemic review and meta-analysis published on January 13, 2025, in JAMA Internal Medicine.

Terri D’Arrigo

On December 20, 2024, FDA approved Zepbound (tirzepatide) for the treatment of obstructive sleep apnea in adults with obesity, to be used in combination with a reduced calorie diet and increased physical activity.

Lauren Howell, PharmD

For decades, BMI has been the go-to measure for defining obesity. But a recent report, published on January 14, 2025, in The Lancet Diabetes & Endocrinology and endorsed by 76 global organizations, suggested that BMI alone is an outdated metric that fails to capture the complexity of obesity.

Aiya Almogaber, PharmD